tiprankstipranks
Advertisement
Advertisement

SLNO Stock Latest News

Neurocrine price target raised to $207 from $190 at Piper Sandler
The FlyNeurocrine price target raised to $207 from $190 at Piper Sandler
4d ago
NBIX
SLNO
Soleno Therapeutics call volume above normal and directionally bullish
PremiumThe Fly
Soleno Therapeutics call volume above normal and directionally bullish
23d ago
SLNO
Wells Fargo downgrades Soleno on pending acquisition
PremiumThe Fly
Wells Fargo downgrades Soleno on pending acquisition
23d ago
NBIX
SLNO
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Soleno Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
24d ago
SLNO
Soleno’s VYKAT XR Real-World Study Adds Fuel to the Prader-Willi Investment Story
PremiumCompany Announcements
Soleno’s VYKAT XR Real-World Study Adds Fuel to the Prader-Willi Investment Story
24d ago
SLNO
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
1M ago
EH
CGC
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Soleno Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
SLNO
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
1M ago
AMGN
NBIX
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
1M ago
ARM
WAL
Soleno Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Soleno Therapeutics downgraded to Neutral from Overweight at Piper Sandler
1M ago
SLNO
Neurocrine price target raised to $166 from $151 at Wedbush
PremiumThe Fly
Neurocrine price target raised to $166 from $151 at Wedbush
1M ago
NBIX
SLNO
Soleno Withdraws EU Application for Prader-Willi Treatment
PremiumCompany Announcements
Soleno Withdraws EU Application for Prader-Willi Treatment
1M ago
8K
SLNO
Neurocrine price target raised to $199 from $190 at BofA
PremiumThe FlyNeurocrine price target raised to $199 from $190 at BofA
1M ago
NBIX
SLNO
Neurocrine price target raised to $166 from $151 at Baird
Premium
The Fly
Neurocrine price target raised to $166 from $151 at Baird
1M ago
NBIX
SLNO
Neurocrine price target raised to $200 from $164 at Canaccord
Premium
The Fly
Neurocrine price target raised to $200 from $164 at Canaccord
1M ago
NBIX
SLNO
Soleno Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Soleno Therapeutics downgraded to Hold from Buy at Stifel
1M ago
SLNO
Soleno Therapeutics downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Soleno Therapeutics downgraded to Hold from Buy at TD Cowen
1M ago
SLNO
Hold Rating on Soleno Reflects Capped Upside Under Neurocrine Takeover Agreement
PremiumRatings
Hold Rating on Soleno Reflects Capped Upside Under Neurocrine Takeover Agreement
1M ago
SLNO
Soleno downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Soleno downgraded to Perform from Outperform at Oppenheimer
1M ago
SLNO
Soleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlySoleno Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
1M ago
SLNO
Neurocrine price target raised to $220 from $192 at Oppenheimer
Premium
The Fly
Neurocrine price target raised to $220 from $192 at Oppenheimer
1M ago
NBIX
SLNO
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
Premium
The Fly
Soleno Therapeutics downgraded to Neutral from Outperform at Baird
1M ago
SLNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >